{
  "id": 882512,
  "title": "Abcuro gets $66M for Phase 3 in muscle-weakening condition",
  "url": "https://urgent.news/2026/08/14/abcuro-gets-66m-for-phase-3-in-muscle-weakening-condition",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-14T15:28:46.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/abcuro-gets-66m-for-phase-3-in-muscle-weakening-condition/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Abcuro has collected $66 million a few months after saying its sole drug missed the mark in a muscle-weakening condition but had found hope in a subset of patients with less severe forms. CEO Alex ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}